Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin.
about
Nanoparticle-mediated drug delivery for treating melanomaCisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic studyH-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptorVascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.Nanoparticles and nanofibers for topical drug delivery.Synthetic and bioinspired cage nanoparticles for drug delivery.Functionalized protein nanocages as a platform of targeted therapy and immunodetection.Ferritin cage for encapsulation and delivery of bioactive nutrients: From structure, property to applications.The regulatory mechanisms of NG2/CSPG4 expression.Platinum-conjugated antibodies for application in mass cytometry.Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin.Humanized archaeal ferritin as a tool for cell targeted delivery.Conversion of the Native 24-mer Ferritin Nanocage into Its Non-Native 16-mer Analogue by Insertion of Extra Amino Acid Residues.X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage.CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.Engineering protein interfaces yields ferritin disassembly and reassembly under benign experimental conditions.
P2860
Q26798379-30E09AD0-EE29-4D78-9445-549CFD7CCEAFQ27704043-FE418E31-F3D3-45E7-BB91-B199B98D79EBQ34383748-8AA289E9-C9FD-437F-8867-CCE07BC0FFC9Q36078281-ECD6931C-5DD1-4CB8-92B3-4A07F29F554BQ36693096-971BE69A-74AD-4257-98A0-F50A5D943B7FQ36978587-CE3C24B2-B85B-4042-839E-3C1C83951800Q38254088-AA03E370-3D21-4113-B001-031B029C1401Q38664186-64B4AC94-14AE-44D1-B6B0-629CA89E47C5Q38776237-6BC0A213-3950-4D87-B348-3045E9E1C5E1Q39325532-6DB08B02-97E8-4B2D-9571-B9D7E8454B4EQ41007441-0982D75B-5C5C-4362-B116-6ED8E50076E7Q41183225-B6F23B69-B2BC-414C-A92B-78016AAB82EEQ45858764-D40591D9-45DD-4E01-9862-609CCAB86B61Q48165104-E7FBC8A8-75BC-4BB4-BA64-07306F130789Q48923575-DCB66065-F750-44B3-9C43-ADEA49471AFAQ50905102-1BD83D95-ABD9-4F1A-9A9F-7B120A1043AAQ50918966-BFA4B8B1-9734-4042-BC14-E149A9FE6E46Q51326343-B1C952FF-AEB0-4AEC-8C8F-4CDC1CDE9BCC
P2860
Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Antibody-drug conjugates: targ ...... icles based on human ferritin.
@en
Antibody-drug conjugates: targ ...... icles based on human ferritin.
@nl
type
label
Antibody-drug conjugates: targ ...... icles based on human ferritin.
@en
Antibody-drug conjugates: targ ...... icles based on human ferritin.
@nl
prefLabel
Antibody-drug conjugates: targ ...... icles based on human ferritin.
@en
Antibody-drug conjugates: targ ...... icles based on human ferritin.
@nl
P2860
P50
P356
P1433
P1476
Antibody-drug conjugates: targ ...... icles based on human ferritin.
@en
P2093
Alberto Boffi
Carlotta Zamparelli
P2860
P304
12278-12285
P356
10.1039/C3NR04268E
P407
P50
P577
2013-12-01T00:00:00Z